Mercury Laboratories Ltd
BSE:538964

Watchlist Manager
Mercury Laboratories Ltd Logo
Mercury Laboratories Ltd
BSE:538964
Watchlist
Price: 814.8 INR 1.88% Market Closed
Market Cap: ₹977.8m

Operating Margin

6.2%
Current
Declining
by 0.8%
vs 3-y average of 7%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.2%
=
Operating Income
₹47.4m
/
Revenue
₹765.6m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
6.2%
=
Operating Income
₹47.4m
/
Revenue
₹765.6m

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Mercury Laboratories Ltd
BSE:538964
977.8m INR
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
972.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
547.5B USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
277.1B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
272.1B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...

Market Distribution

In line with most companies in India
Percentile
45th
Based on 5 437 companies
45th percentile
6.2%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Mercury Laboratories Ltd
Glance View

Market Cap
977.8m INR
Industry
N/A

Mercury Laboratories Ltd. engages in the production and sale of pharmaceuticals and its related products. The company is headquartered in Vadodara, Gujarat. The company went IPO on 2015-02-23. The firm is engaged in the manufacturing of pharmaceuticals, medicinal drugs and formulations. The Company’s products include Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti-malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin, Protein supplement, Respiratory System, Anti- allergic, Steroids, Urinary system, Uterine stimulant and Miscellaneous. Its products also include Gynec, Paediatric, Surgeon, Physician, Antihypertensive (PIH), PCOS & Uterine Disorders, Galactagogue, Haemostat, Iron and Vitamins, Preterm Labor Management, Antiemetic, Dexamethasone Tablet, Glucosamine Sulphate, Prednisolone Acetate Ophthalmic Suspension USP, Ketorolac Tromethamine 0.4% Eye Drops and Ketorolac Tromethamine 0.4% Eye Drops.

MERCURYLAB Intrinsic Value
758.95 INR
Overvaluation 7%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
6.2%
=
Operating Income
₹47.4m
/
Revenue
₹765.6m
What is Mercury Laboratories Ltd's current Operating Margin?

The current Operating Margin for Mercury Laboratories Ltd is 6.2%, which is below its 3-year median of 7%.

How has Operating Margin changed over time?

Over the last 3 years, Mercury Laboratories Ltd’s Operating Margin has decreased from 7.6% to 6.2%. During this period, it reached a low of 4.1% on Sep 30, 2023 and a high of 10.6% on Sep 30, 2022.

Back to Top